Chemoinformaics analysis of 2-METHYLBUTANENITRILE
| Molecular Weight | 83.134 | nRot | 1 |
| Heavy Atom Molecular Weight | 74.062 | nRig | 0 |
| Exact Molecular Weight | 83.0735 | nRing | 0 |
| Solubility: LogS | -5.72 | nHRing | 0 |
| Solubility: LogP | 5.668 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 15 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 6 | No. of Aromatic Carbocycles | 0 |
| nHetero | 1 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 9 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 5 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 1 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 0 | No. of Arom Bond | 0 |
| nHA | 1 | APOL | 15.4511 |
| nHD | 0 | BPOL | 9.59886 |
| QED | 0.468 |
| Synth | 1.226 |
| Natural Product Likeliness | 0.244 |
| NR-PPAR-gamma | 0.019 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Rejected |
| Golden Triangle | Rejected |
| Pgp-inh | 0.004 |
| Pgp-sub | 0.002 |
| HIA | 0.002 |
| CACO-2 | -4.402 |
| MDCK | 0.0000133 |
| BBB | 0.808 |
| PPB | 0.971401 |
| VDSS | 3.073 |
| FU | 0.0274242 |
| CYP1A2-inh | 0.945 |
| CYP1A2-sub | 0.43 |
| CYP2c19-inh | 0.591 |
| CYP2c19-sub | 0.445 |
| CYP2c9-inh | 0.343 |
| CYP2c9-sub | 0.911 |
| CYP2d6-inh | 0.068 |
| CYP2d6-sub | 0.108 |
| CYP3a4-inh | 0.113 |
| CYP3a4-sub | 0.094 |
| CL | 5.461 |
| T12 | 0.221 |
| hERG | 0.1 |
| Ames | 0.008 |
| ROA | 0.06 |
| SkinSen | 0.891 |
| Carcinogencity | 0.058 |
| EI | 0.973 |
| Respiratory | 0.588 |
| NR-Aromatase | 0.012 |
| Antiviral | No |
| Prediction | 0.944861 |